Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2025-12-26 @ 3:18 AM
NCT ID: NCT01975220
Description: None
Frequency Threshold: 5
Time Frame: From first trial medication intake until next intake or the end-of-trial visit, 10 days
Study: NCT01975220
Study Brief: Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
High Dose, Fasted: 1 FDC Tablet 1 fixed dose combination (FDC) tablet under fasted conditions: 25 mg Empagliflozin/1000 mg Metformin XR (extended release), FDC: Experimental, high dose Empagliflozin/Metformin XR, FDC tablet None None 0 23 4 23 View
High Dose, Fasted: 3 Single Tablets 3 single tablets under fasted conditions: 1 x 25 mg tablet Empagliflozin / 2 x 500 mg tablets Metformin XR: Active Comparator: 1x Empagliflozin / 2x Metformin XR tablets None None 0 23 1 23 View
High Dose, Fed: 1 FDC Tablet 1 fixed dose combination (FDC) tablet under fed conditions: 25 mg Empagliflozin/1000 mg Metformin XR, FDC: Experimental, high dose Empagliflozin/Metformin XR,FDC tablet None None 0 24 1 24 View
High Dose, Fed: 3 Single Tablets 3 single tablets under fed conditions: 1 x 25 mg tablet Empagliflozin / 2 x 500 mg tablets Metformin XR: Active Comparator: 1x Empagliflozin / 2x Metformin XR tablets None None 0 24 2 24 View
Low Dose, Fasted: 2 FDC Tablets 2 fixed dose combination (FDC) tablets under fasted conditions: 12.5 mg Empagliflozin / 750 mg Metformin XR FDC tablets: Experimental: low dose Empagliflozin/Metformin XR, 2 FDC tablets None None 0 24 4 24 View
Low Dose, Fasted: 4 Single Tablets 4 single tablets under fed conditions: 1 x 25 mg tablet Empagliflozin / 3 x 500 mg tablets Metformin XR: Active Comparator: 1x Empagliflozin / 3x Metformin XR tablets None None 0 24 1 24 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MEDDRA 16.1 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MEDDRA 16.1 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MEDDRA 16.1 View